Skip to main content
. 2014 Aug 11;14:830. doi: 10.1186/1471-2458-14-830

Table 2.

Correlates of HCV seropositivity in injecting cohort with in prison test results

N participants (% of those answering interview question) N seropositive (% of category) Univariate odds ratio (95% confidence interval) Multivariable odds ratio (95% confidence interval)
Female (vs. male) 191 (21.8) 54 (61.4) 2.06 (1.27, 3.35) 2.74 (1.45, 5.18)
Indigenous (vs. non-indigenous) 91 (22.6) 40 (44.0) 0.84 (0.53, 1.35) 0.76 (0.42, 1.36)
Educated 10 years or more (vs. <10 years) 196 (48.6) 86 (43.4) 0.73 (0.49, 1.08) 0.79 (0.48, 1.29)
Injecting 10 years or more (vs. <10 years) 210 (52.2) 97 (46.2) 3.03 (1.66, 5.54) 2.83 (1.38, 5.78)
Injecting 20 years or more (vs. <10 years) 115 (28.6) 76 (66.1) 6.88 (3.55, 13.34) 4.54 (2.05, 10.1)
Heroin injection (vs. other drugs) 163 (40.8) 87 (53.4) 3.66 (2.25, 5.94) 1.95 (1.11, 3.43)
Heroin injection with OST (vs. other drugs) 86 (21.5) 66 (76.7) 10.5 (5.64, 19.7) 4.13 (2.02, 8.42)
Shared injecting equipment in community (vs. no sharing, no prison IDU) 109 (27.1) 64 (58.7) 4.91 (2.83, 8.53) 3.19 (1.69, 6.04)
Injected in prison (vs. no sharing, no prison IDU) 156 (38.7) 96 (61.5) 5.52 (3.30, 9.23) 3.57 (1.94, 6.57)
Tattoos (vs. no tattoos) 340 (84.4) 171 (50.3) 2.18 (1.23, 3.85) 1.38 (0.70, 4.98)
Prior incarceration as adult only (vs. none) 209 (51.9) 99 (47.4) 2.70 (1.30, 5.63) 2.05 (0.84, 4.98)
Prior incarceration as juvenile (vs. none) 150 (37.2) 81 (54.0) 3.52 (1.66, 7.49) 3.07 (1.20, 7.88)